Global Non-prescription Mouthrinse Market Growth 2022-2028
- LP 4952302
- 110 Pages
- May 2022
- Consumer Goods
The United States Non-prescription Mouthrinse market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Non-prescription Mouthrinse market, reaching US$ million by the year 2028. As for the Europe Non-prescription Mouthrinse landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Non-prescription Mouthrinse players cover Johnson & Johnson, Sunstar, P&G, and Lion, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-prescription Mouthrinse market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Alcoholic
Non-alcoholic
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hypermarket and Supermarket
Convenience Stores
Online Sale
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Johnson & Johnson
Sunstar
P&G
Lion
Colgate-Palmolive
Unilever
Church & Dwight
PIERAS CO
GSK
Caldwell Consumer Health
Weleda
Dentyl Active
Kao Corporation
NYSCPS
WEIMEIZI (GUANGDONG) CO.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-prescription Mouthrinse Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Non-prescription Mouthrinse by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Non-prescription Mouthrinse by Country/Region, 2017, 2022 & 2028
2.2 Non-prescription Mouthrinse Segment by Type
2.2.1 Alcoholic
2.2.2 Non-alcoholic
2.3 Non-prescription Mouthrinse Sales by Type
2.3.1 Global Non-prescription Mouthrinse Sales Market Share by Type (2017-2022)
2.3.2 Global Non-prescription Mouthrinse Revenue and Market Share by Type (2017-2022)
2.3.3 Global Non-prescription Mouthrinse Sale Price by Type (2017-2022)
2.4 Non-prescription Mouthrinse Segment by Application
2.4.1 Hypermarket and Supermarket
2.4.2 Convenience Stores
2.4.3 Online Sale
2.5 Non-prescription Mouthrinse Sales by Application
2.5.1 Global Non-prescription Mouthrinse Sale Market Share by Application (2017-2022)
2.5.2 Global Non-prescription Mouthrinse Revenue and Market Share by Application (2017-2022)
2.5.3 Global Non-prescription Mouthrinse Sale Price by Application (2017-2022)
3 Global Non-prescription Mouthrinse by Company
3.1 Global Non-prescription Mouthrinse Breakdown Data by Company
3.1.1 Global Non-prescription Mouthrinse Annual Sales by Company (2020-2022)
3.1.2 Global Non-prescription Mouthrinse Sales Market Share by Company (2020-2022)
3.2 Global Non-prescription Mouthrinse Annual Revenue by Company (2020-2022)
3.2.1 Global Non-prescription Mouthrinse Revenue by Company (2020-2022)
3.2.2 Global Non-prescription Mouthrinse Revenue Market Share by Company (2020-2022)
3.3 Global Non-prescription Mouthrinse Sale Price by Company
3.4 Key Manufacturers Non-prescription Mouthrinse Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-prescription Mouthrinse Product Location Distribution
3.4.2 Players Non-prescription Mouthrinse Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-prescription Mouthrinse by Geographic Region
4.1 World Historic Non-prescription Mouthrinse Market Size by Geographic Region (2017-2022)
4.1.1 Global Non-prescription Mouthrinse Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Non-prescription Mouthrinse Annual Revenue by Geographic Region
4.2 World Historic Non-prescription Mouthrinse Market Size by Country/Region (2017-2022)
4.2.1 Global Non-prescription Mouthrinse Annual Sales by Country/Region (2017-2022)
4.2.2 Global Non-prescription Mouthrinse Annual Revenue by Country/Region
4.3 Americas Non-prescription Mouthrinse Sales Growth
4.4 APAC Non-prescription Mouthrinse Sales Growth
4.5 Europe Non-prescription Mouthrinse Sales Growth
4.6 Middle East & Africa Non-prescription Mouthrinse Sales Growth
5 Americas
5.1 Americas Non-prescription Mouthrinse Sales by Country
5.1.1 Americas Non-prescription Mouthrinse Sales by Country (2017-2022)
5.1.2 Americas Non-prescription Mouthrinse Revenue by Country (2017-2022)
5.2 Americas Non-prescription Mouthrinse Sales by Type
5.3 Americas Non-prescription Mouthrinse Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-prescription Mouthrinse Sales by Region
6.1.1 APAC Non-prescription Mouthrinse Sales by Region (2017-2022)
6.1.2 APAC Non-prescription Mouthrinse Revenue by Region (2017-2022)
6.2 APAC Non-prescription Mouthrinse Sales by Type
6.3 APAC Non-prescription Mouthrinse Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-prescription Mouthrinse by Country
7.1.1 Europe Non-prescription Mouthrinse Sales by Country (2017-2022)
7.1.2 Europe Non-prescription Mouthrinse Revenue by Country (2017-2022)
7.2 Europe Non-prescription Mouthrinse Sales by Type
7.3 Europe Non-prescription Mouthrinse Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-prescription Mouthrinse by Country
8.1.1 Middle East & Africa Non-prescription Mouthrinse Sales by Country (2017-2022)
8.1.2 Middle East & Africa Non-prescription Mouthrinse Revenue by Country (2017-2022)
8.2 Middle East & Africa Non-prescription Mouthrinse Sales by Type
8.3 Middle East & Africa Non-prescription Mouthrinse Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-prescription Mouthrinse
10.3 Manufacturing Process Analysis of Non-prescription Mouthrinse
10.4 Industry Chain Structure of Non-prescription Mouthrinse
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-prescription Mouthrinse Distributors
11.3 Non-prescription Mouthrinse Customer
12 World Forecast Review for Non-prescription Mouthrinse by Geographic Region
12.1 Global Non-prescription Mouthrinse Market Size Forecast by Region
12.1.1 Global Non-prescription Mouthrinse Forecast by Region (2023-2028)
12.1.2 Global Non-prescription Mouthrinse Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-prescription Mouthrinse Forecast by Type
12.7 Global Non-prescription Mouthrinse Forecast by Application
13 Key Players Analysis
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Non-prescription Mouthrinse Product Offered
13.1.3 Johnson & Johnson Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Sunstar
13.2.1 Sunstar Company Information
13.2.2 Sunstar Non-prescription Mouthrinse Product Offered
13.2.3 Sunstar Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sunstar Main Business Overview
13.2.5 Sunstar Latest Developments
13.3 P&G
13.3.1 P&G Company Information
13.3.2 P&G Non-prescription Mouthrinse Product Offered
13.3.3 P&G Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 P&G Main Business Overview
13.3.5 P&G Latest Developments
13.4 Lion
13.4.1 Lion Company Information
13.4.2 Lion Non-prescription Mouthrinse Product Offered
13.4.3 Lion Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lion Main Business Overview
13.4.5 Lion Latest Developments
13.5 Colgate-Palmolive
13.5.1 Colgate-Palmolive Company Information
13.5.2 Colgate-Palmolive Non-prescription Mouthrinse Product Offered
13.5.3 Colgate-Palmolive Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Colgate-Palmolive Main Business Overview
13.5.5 Colgate-Palmolive Latest Developments
13.6 Unilever
13.6.1 Unilever Company Information
13.6.2 Unilever Non-prescription Mouthrinse Product Offered
13.6.3 Unilever Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Unilever Main Business Overview
13.6.5 Unilever Latest Developments
13.7 Church & Dwight
13.7.1 Church & Dwight Company Information
13.7.2 Church & Dwight Non-prescription Mouthrinse Product Offered
13.7.3 Church & Dwight Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Church & Dwight Main Business Overview
13.7.5 Church & Dwight Latest Developments
13.8 PIERAS CO
13.8.1 PIERAS CO Company Information
13.8.2 PIERAS CO Non-prescription Mouthrinse Product Offered
13.8.3 PIERAS CO Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 PIERAS CO Main Business Overview
13.8.5 PIERAS CO Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Non-prescription Mouthrinse Product Offered
13.9.3 GSK Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Caldwell Consumer Health
13.10.1 Caldwell Consumer Health Company Information
13.10.2 Caldwell Consumer Health Non-prescription Mouthrinse Product Offered
13.10.3 Caldwell Consumer Health Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Caldwell Consumer Health Main Business Overview
13.10.5 Caldwell Consumer Health Latest Developments
13.11 Weleda
13.11.1 Weleda Company Information
13.11.2 Weleda Non-prescription Mouthrinse Product Offered
13.11.3 Weleda Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Weleda Main Business Overview
13.11.5 Weleda Latest Developments
13.12 Dentyl Active
13.12.1 Dentyl Active Company Information
13.12.2 Dentyl Active Non-prescription Mouthrinse Product Offered
13.12.3 Dentyl Active Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Dentyl Active Main Business Overview
13.12.5 Dentyl Active Latest Developments
13.13 Kao Corporation
13.13.1 Kao Corporation Company Information
13.13.2 Kao Corporation Non-prescription Mouthrinse Product Offered
13.13.3 Kao Corporation Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Kao Corporation Main Business Overview
13.13.5 Kao Corporation Latest Developments
13.14 NYSCPS
13.14.1 NYSCPS Company Information
13.14.2 NYSCPS Non-prescription Mouthrinse Product Offered
13.14.3 NYSCPS Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 NYSCPS Main Business Overview
13.14.5 NYSCPS Latest Developments
13.15 WEIMEIZI (GUANGDONG) CO.
13.15.1 WEIMEIZI (GUANGDONG) CO. Company Information
13.15.2 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Offered
13.15.3 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 WEIMEIZI (GUANGDONG) CO. Main Business Overview
13.15.5 WEIMEIZI (GUANGDONG) CO. Latest Developments
14 Research Findings and Conclusion
Table 1. Non-prescription Mouthrinse Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Non-prescription Mouthrinse Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Alcoholic
Table 4. Major Players of Non-alcoholic
Table 5. Global Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 6. Global Non-prescription Mouthrinse Sales Market Share by Type (2017-2022)
Table 7. Global Non-prescription Mouthrinse Revenue by Type (2017-2022) & ($ million)
Table 8. Global Non-prescription Mouthrinse Revenue Market Share by Type (2017-2022)
Table 9. Global Non-prescription Mouthrinse Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 11. Global Non-prescription Mouthrinse Sales Market Share by Application (2017-2022)
Table 12. Global Non-prescription Mouthrinse Revenue by Application (2017-2022)
Table 13. Global Non-prescription Mouthrinse Revenue Market Share by Application (2017-2022)
Table 14. Global Non-prescription Mouthrinse Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Non-prescription Mouthrinse Sales by Company (2020-2022) & (K Units)
Table 16. Global Non-prescription Mouthrinse Sales Market Share by Company (2020-2022)
Table 17. Global Non-prescription Mouthrinse Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Non-prescription Mouthrinse Revenue Market Share by Company (2020-2022)
Table 19. Global Non-prescription Mouthrinse Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Non-prescription Mouthrinse Producing Area Distribution and Sales Area
Table 21. Players Non-prescription Mouthrinse Products Offered
Table 22. Non-prescription Mouthrinse Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Non-prescription Mouthrinse Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Non-prescription Mouthrinse Sales Market Share Geographic Region (2017-2022)
Table 27. Global Non-prescription Mouthrinse Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Non-prescription Mouthrinse Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Non-prescription Mouthrinse Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Non-prescription Mouthrinse Sales Market Share by Country/Region (2017-2022)
Table 31. Global Non-prescription Mouthrinse Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Non-prescription Mouthrinse Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Non-prescription Mouthrinse Sales by Country (2017-2022) & (K Units)
Table 34. Americas Non-prescription Mouthrinse Sales Market Share by Country (2017-2022)
Table 35. Americas Non-prescription Mouthrinse Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Non-prescription Mouthrinse Revenue Market Share by Country (2017-2022)
Table 37. Americas Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 38. Americas Non-prescription Mouthrinse Sales Market Share by Type (2017-2022)
Table 39. Americas Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 40. Americas Non-prescription Mouthrinse Sales Market Share by Application (2017-2022)
Table 41. APAC Non-prescription Mouthrinse Sales by Region (2017-2022) & (K Units)
Table 42. APAC Non-prescription Mouthrinse Sales Market Share by Region (2017-2022)
Table 43. APAC Non-prescription Mouthrinse Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Non-prescription Mouthrinse Revenue Market Share by Region (2017-2022)
Table 45. APAC Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 46. APAC Non-prescription Mouthrinse Sales Market Share by Type (2017-2022)
Table 47. APAC Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 48. APAC Non-prescription Mouthrinse Sales Market Share by Application (2017-2022)
Table 49. Europe Non-prescription Mouthrinse Sales by Country (2017-2022) & (K Units)
Table 50. Europe Non-prescription Mouthrinse Sales Market Share by Country (2017-2022)
Table 51. Europe Non-prescription Mouthrinse Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Non-prescription Mouthrinse Revenue Market Share by Country (2017-2022)
Table 53. Europe Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 54. Europe Non-prescription Mouthrinse Sales Market Share by Type (2017-2022)
Table 55. Europe Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 56. Europe Non-prescription Mouthrinse Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Non-prescription Mouthrinse Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Non-prescription Mouthrinse Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Non-prescription Mouthrinse Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Non-prescription Mouthrinse Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Non-prescription Mouthrinse Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Non-prescription Mouthrinse Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Non-prescription Mouthrinse
Table 66. Key Market Challenges & Risks of Non-prescription Mouthrinse
Table 67. Key Industry Trends of Non-prescription Mouthrinse
Table 68. Non-prescription Mouthrinse Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Non-prescription Mouthrinse Distributors List
Table 71. Non-prescription Mouthrinse Customer List
Table 72. Global Non-prescription Mouthrinse Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Non-prescription Mouthrinse Sales Market Forecast by Region
Table 74. Global Non-prescription Mouthrinse Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Non-prescription Mouthrinse Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Non-prescription Mouthrinse Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Non-prescription Mouthrinse Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Non-prescription Mouthrinse Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Non-prescription Mouthrinse Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Non-prescription Mouthrinse Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Non-prescription Mouthrinse Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Non-prescription Mouthrinse Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Non-prescription Mouthrinse Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Non-prescription Mouthrinse Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Non-prescription Mouthrinse Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Non-prescription Mouthrinse Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Non-prescription Mouthrinse Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Non-prescription Mouthrinse Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Non-prescription Mouthrinse Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Non-prescription Mouthrinse Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Non-prescription Mouthrinse Revenue Market Share Forecast by Application (2023-2028)
Table 92. Johnson & Johnson Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson Non-prescription Mouthrinse Product Offered
Table 94. Johnson & Johnson Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 97. Sunstar Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 98. Sunstar Non-prescription Mouthrinse Product Offered
Table 99. Sunstar Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sunstar Main Business
Table 101. Sunstar Latest Developments
Table 102. P&G Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 103. P&G Non-prescription Mouthrinse Product Offered
Table 104. P&G Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. P&G Main Business
Table 106. P&G Latest Developments
Table 107. Lion Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 108. Lion Non-prescription Mouthrinse Product Offered
Table 109. Lion Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Lion Main Business
Table 111. Lion Latest Developments
Table 112. Colgate-Palmolive Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 113. Colgate-Palmolive Non-prescription Mouthrinse Product Offered
Table 114. Colgate-Palmolive Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Colgate-Palmolive Main Business
Table 116. Colgate-Palmolive Latest Developments
Table 117. Unilever Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 118. Unilever Non-prescription Mouthrinse Product Offered
Table 119. Unilever Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Unilever Main Business
Table 121. Unilever Latest Developments
Table 122. Church & Dwight Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 123. Church & Dwight Non-prescription Mouthrinse Product Offered
Table 124. Church & Dwight Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Church & Dwight Main Business
Table 126. Church & Dwight Latest Developments
Table 127. PIERAS CO Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 128. PIERAS CO Non-prescription Mouthrinse Product Offered
Table 129. PIERAS CO Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. PIERAS CO Main Business
Table 131. PIERAS CO Latest Developments
Table 132. GSK Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 133. GSK Non-prescription Mouthrinse Product Offered
Table 134. GSK Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. GSK Main Business
Table 136. GSK Latest Developments
Table 137. Caldwell Consumer Health Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 138. Caldwell Consumer Health Non-prescription Mouthrinse Product Offered
Table 139. Caldwell Consumer Health Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Caldwell Consumer Health Main Business
Table 141. Caldwell Consumer Health Latest Developments
Table 142. Weleda Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 143. Weleda Non-prescription Mouthrinse Product Offered
Table 144. Weleda Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Weleda Main Business
Table 146. Weleda Latest Developments
Table 147. Dentyl Active Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 148. Dentyl Active Non-prescription Mouthrinse Product Offered
Table 149. Dentyl Active Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Dentyl Active Main Business
Table 151. Dentyl Active Latest Developments
Table 152. Kao Corporation Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 153. Kao Corporation Non-prescription Mouthrinse Product Offered
Table 154. Kao Corporation Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Kao Corporation Main Business
Table 156. Kao Corporation Latest Developments
Table 157. NYSCPS Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 158. NYSCPS Non-prescription Mouthrinse Product Offered
Table 159. NYSCPS Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. NYSCPS Main Business
Table 161. NYSCPS Latest Developments
Table 162. WEIMEIZI (GUANGDONG) CO. Basic Information, Non-prescription Mouthrinse Manufacturing Base, Sales Area and Its Competitors
Table 163. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Offered
Table 164. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. WEIMEIZI (GUANGDONG) CO. Main Business
Table 166. WEIMEIZI (GUANGDONG) CO. Latest Developments
List of Figures
Figure 1. Picture of Non-prescription Mouthrinse
Figure 2. Non-prescription Mouthrinse Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-prescription Mouthrinse Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Non-prescription Mouthrinse Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Non-prescription Mouthrinse Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Alcoholic
Figure 10. Product Picture of Non-alcoholic
Figure 11. Global Non-prescription Mouthrinse Sales Market Share by Type in 2021
Figure 12. Global Non-prescription Mouthrinse Revenue Market Share by Type (2017-2022)
Figure 13. Non-prescription Mouthrinse Consumed in Hypermarket and Supermarket
Figure 14. Global Non-prescription Mouthrinse Market: Hypermarket and Supermarket (2017-2022) & (K Units)
Figure 15. Non-prescription Mouthrinse Consumed in Convenience Stores
Figure 16. Global Non-prescription Mouthrinse Market: Convenience Stores (2017-2022) & (K Units)
Figure 17. Non-prescription Mouthrinse Consumed in Online Sale
Figure 18. Global Non-prescription Mouthrinse Market: Online Sale (2017-2022) & (K Units)
Figure 19. Global Non-prescription Mouthrinse Sales Market Share by Application (2017-2022)
Figure 20. Global Non-prescription Mouthrinse Revenue Market Share by Application in 2021
Figure 21. Non-prescription Mouthrinse Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Non-prescription Mouthrinse Revenue Market Share by Company in 2021
Figure 23. Global Non-prescription Mouthrinse Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Non-prescription Mouthrinse Revenue Market Share by Geographic Region in 2021
Figure 25. Global Non-prescription Mouthrinse Sales Market Share by Region (2017-2022)
Figure 26. Global Non-prescription Mouthrinse Revenue Market Share by Country/Region in 2021
Figure 27. Americas Non-prescription Mouthrinse Sales 2017-2022 (K Units)
Figure 28. Americas Non-prescription Mouthrinse Revenue 2017-2022 ($ Millions)
Figure 29. APAC Non-prescription Mouthrinse Sales 2017-2022 (K Units)
Figure 30. APAC Non-prescription Mouthrinse Revenue 2017-2022 ($ Millions)
Figure 31. Europe Non-prescription Mouthrinse Sales 2017-2022 (K Units)
Figure 32. Europe Non-prescription Mouthrinse Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Non-prescription Mouthrinse Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Non-prescription Mouthrinse Revenue 2017-2022 ($ Millions)
Figure 35. Americas Non-prescription Mouthrinse Sales Market Share by Country in 2021
Figure 36. Americas Non-prescription Mouthrinse Revenue Market Share by Country in 2021
Figure 37. United States Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Non-prescription Mouthrinse Sales Market Share by Region in 2021
Figure 42. APAC Non-prescription Mouthrinse Revenue Market Share by Regions in 2021
Figure 43. China Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Non-prescription Mouthrinse Sales Market Share by Country in 2021
Figure 50. Europe Non-prescription Mouthrinse Revenue Market Share by Country in 2021
Figure 51. Germany Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Non-prescription Mouthrinse Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Non-prescription Mouthrinse Revenue Market Share by Country in 2021
Figure 58. Egypt Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Non-prescription Mouthrinse Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Non-prescription Mouthrinse in 2021
Figure 64. Manufacturing Process Analysis of Non-prescription Mouthrinse
Figure 65. Industry Chain Structure of Non-prescription Mouthrinse
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
School uniforms are a product targeted at a particular section of the society. A growing market for private education and schooling in India is providing growth prospects to this industry. Furthermore, players are also interested in increasing their presence and reach in the market. Large players are readily tying up with retail giants and schools towards increasing visibility. State governments a...
- Publish Date: March 7, 2011
- $950
The Smartphones Market in India will be boosted by the increase in the usage of mobile internet along with the availability of 3G services and launch of affordable smartphones with versatile features and applications. Smartphones have also gained popularity amongst the youth due to the available features that suits the business and entertainment needs. The report begins with an overview of the sm...
- Publish Date: March 16, 2011
- $950
E-governance is at its nascent stage in India with strong potential for growth in the future. The Information Technology (IT) industry is expected to be the major industry that stands to benefit. Government spending on IT is rapidly increasing which opens newer opportunities for the players in the IT space. It also provides growth prospects to various industries which are likely to benefit from th...
- Publish Date: March 28, 2011
- $950
